Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Sufei Zheng"'
Autor:
Chengming Liu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Xinfeng Wang, Lu Yang, Haiyan Xu, Zheng Cao, Xiaoli Feng, Qi Xue, Yan Wang, Nan Sun, Jie He
Publikováno v:
Cancer Communications, Vol 42, Iss 9, Pp 828-847 (2022)
Abstract Background Although immune checkpoint inhibitors (ICIs) against programmed cell death protein 1 (PD‐1) and its ligand PD‐L1 have demonstrated potency towards treating patients with non‐small cell lung carcinoma (NSCLC), the potential a
Externí odkaz:
https://doaj.org/article/b8bb7a9a6c6a46f98594887e66e97fbe
Publikováno v:
Genes and Diseases, Vol 10, Iss 1, Pp 48-50 (2023)
Externí odkaz:
https://doaj.org/article/441fe45f701244ccbf133d83a92c6d7a
Autor:
Xinfeng Wang, Yuan Li, Runsen Jin, Sufei Zheng, Yuejun Luo, Peng Wu, Zhanyu Wang, Yuxin Yao, Nan Sun, Jie He
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/03858df2f20248de8d095861bca93c3c
Autor:
Chengming Liu, Sufei Zheng, Zhiliang Lu, Zhanyu Wang, Sihui Wang, Xiaoli Feng, Yan Wang, Nan Sun, Jie He
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/69714a8870ab4799a59e0fbd4366c426
Autor:
Chengming Liu, Lu Yang, Haiyan Xu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Yaning Yang, Shuyang Zhang, Xiaoli Feng, Nan Sun, Yan Wang, Jie He
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Cytokines have been reported to alter the response to immune checkpoint inhibitors (ICIs) in patients with the tumor in accordance with their plasma concentrations. Here, we aimed to identify the key cytokines which influenced the
Externí odkaz:
https://doaj.org/article/c2a2507fa5054c5f85cf74082ba6f5cf
Autor:
Feng Wang, Chaoqi Zhang, Hong Cheng, Chengming Liu, Zhiliang Lu, Sufei Zheng, Sihui Wang, Nan Sun, Jie He
Publikováno v:
Cell Death and Disease, Vol 12, Iss 10, Pp 1-12 (2021)
Abstract Oesophageal squamous cell carcinoma (ESCC) has a relatively unfavourable prognosis due to metastasis and chemoresistance. Our previous research established a comprehensive ESCC database (GSE53625). After analysing data from TCGA database and
Externí odkaz:
https://doaj.org/article/31efdca98a964cec8a67925fb06a1023
Autor:
Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun, Jie He
Publikováno v:
Cancer Biology & Medicine, Vol 18, Iss 3, Pp 734-749 (2021)
Objective: The proportion of patients with stage I lung adenocarcinoma (LUAD) has dramatically increased with the prevalence of low-dose computed tomography use for screening. Up to 30% of patients with stage I LUAD experience recurrence within 5 yea
Externí odkaz:
https://doaj.org/article/a2e98395d2bb4b3fbdc05910c0777d22
Autor:
Mingchuang Zhu, Qingpeng Zeng, Tao Fan, Yuanyuan Lei, Feng Wang, Sufei Zheng, Xinfeng Wang, Hui Zeng, Fengwei Tan, Nan Sun, Qi Xue, Jie He
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/40f0cc702acc4cbb9b5f44ee4b079bdf
Autor:
Shuangshuang Mao, Zhiliang Lu, Sufei Zheng, Hao Zhang, Guochao Zhang, Feng Wang, Jianbing Huang, Yuanyuan Lei, Xinfeng Wang, Chengming Liu, Nan Sun, Jie He
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-16 (2020)
Abstract Background Angiogenesis, a basic requirement for tumor cell survival, is considered to be a malignant characteristic of small cell lung cancer (SCLC) and is closely related to the poor outcomes of SCLC patients. miR-141 has been found to pla
Externí odkaz:
https://doaj.org/article/b42899ce4bb04c47985a037b853d13e0
Autor:
Runsen Jin, Chengming Liu, Sufei Zheng, Xinfeng Wang, Xiaoli Feng, Hecheng Li, Nan Sun, Jie He
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 3, Pp 768-781 (2020)
Objective: The aim of this study was to investigate how the tumor immune microenvironment differs regarding tumor genomics, as well as its impact on prognoses and responses to immunotherapy in East Asian patients with non-small cell lung cancer (NSCL
Externí odkaz:
https://doaj.org/article/b0075604b2d24f3f889764b06decc6b8